Identifying key areas for medical informatics research

Recent achievements in genomics and the increased importance of genetics in healthcare are changing the clinical landscape for both research and the treatment of disease. Helping shape this landscape, researchers have identified opportunities for synergies between biomedical and medical informatics.

Genomic medicine is now integrating molecular medicine, which aims to explain life and disease in terms of the presence and regulation of molecular entities, and personalised medicine, which applies genotypic knowledge to identify predisposition to disease and develops therapies adapted to the genotype of individual patients.

The IST-funded SYMBIOmatics project seeks to stimulate such developments and help identify synergies between bioinformatics and medical/health informatics. Completing in September 2006, SYMBIOmatics has already documented the current status of research in biomedical informatics in Europe and identified several important areas of opportunity.

By systematically surveying European expert opinion and analysing the results of Internet surveys, the project team have produced a draft SYMBIOmatics White Paper, which was presented at the ‘ICT for Bio-Medical Sciences’ conference in Brussels on 29-30 June 2006. The paper describes thirty-one areas identified as potential opportunities or challenges, based on the results of the project, and input from an earlier study carried out by another IST project, BIOINFOMED.

Using both facilitated workshops and further online consultation, the project team narrowed the total down to 14 areas considered the highest priority for further research. These are:

  • ID area name priority.
  • Medical genetics databases and initiatives.
  • Gene expression information in medical diagnostics and prognostics.
  • Modelling and simulation of biological structures, processes and diseases.
  • Integration of data from biosensors and medical devices with clinical information systems.
  • Integration of patient molecular data into electronic health records.
  • Systems for clinical decision making.
  • Semantic interoperability and ontologies in biomedicine.
  • Technologies for biomedical information integration.
  • Data interoperability and standards.
  • Connecting biobanks to large-scale databases to enable data mining.
  • Patient-risk profiling and lifestyle management.
  • Applied pharmaceutical research.
  • Clinical and ethical issues related to biomedical data processing.

Why are these areas of such high priority? Graham Cameron of the European Bioinformatics Institute (EBI-EMBL) near Cambridge, UK, explains. "In pharmaco-genomics for example, it is well-known that certain drugs will work well on some people, but not on others. We believe that genetic makeup is an important explanation, but genetic testing is needed to confirm that view."

He continues, "Research in these areas could well bring down the cost of genetic testing enough to put it within the reach of the GP practice. So that GPs would be able to test patients for suitability as to certain treatments before commencing treatment with a particular drug. You could work out, with the help of your GP, if your own cholesterol level or diet is dangerous for you personally, according to your genetic makeup. Imagine the difference this could make for personal lifestyle choices!"

Cameron concludes, "SYMBIOmatics is an information gathering and dissemination exercise, but we hope that the research community will digest the results, and that they will influence the future direction of research within the EU."

Contact:
Graham Cameron
European Bioinformatics Institute (EBI-EMBL)
Wellcome Trust Genome Campus
Hinxton (near Cambridge)
United Kingdom
Tel: +44-1223-494467
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: IST Results Portal

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Model Converts Hospital Records into …

UCLA researchers have developed an AI system that turns fragmented electronic health records (EHR) normally in tables into readable narratives, allowing artificial intelligence to make sense of complex patient histories...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Mayo Clinic's AI Tool Identifies 9 …

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single...

AI Detects Fatty Liver Disease with Ches…

Fatty liver disease, caused by the accumulation of fat in the liver, is estimated to affect one in four people worldwide. If left untreated, it can lead to serious complications...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...